 Pulmonary Disease, Chronic Obstructive
"Pulmonary Disease, Chronic Obstructive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Descriptor ID |
D029424
|
| MeSH Number(s) |
C08.381.495.389
|
| Concept/Terms |
Airflow Obstruction, Chronic- Airflow Obstruction, Chronic
- Airflow Obstructions, Chronic
- Chronic Airflow Obstructions
- Chronic Airflow Obstruction
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Disease, Chronic Obstructive".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Disease, Chronic Obstructive".
This graph shows the total number of publications written about "Pulmonary Disease, Chronic Obstructive" by people in this website by year, and whether "Pulmonary Disease, Chronic Obstructive" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 | | 2002 | 2 | 2 | 4 | | 2003 | 8 | 7 | 15 | | 2004 | 7 | 1 | 8 | | 2005 | 6 | 2 | 8 | | 2006 | 19 | 8 | 27 | | 2007 | 7 | 3 | 10 | | 2008 | 16 | 4 | 20 | | 2009 | 17 | 5 | 22 | | 2010 | 19 | 3 | 22 | | 2011 | 31 | 6 | 37 | | 2012 | 20 | 5 | 25 | | 2013 | 29 | 7 | 36 | | 2014 | 37 | 5 | 42 | | 2015 | 24 | 7 | 31 | | 2016 | 30 | 7 | 37 | | 2017 | 37 | 5 | 42 | | 2018 | 40 | 4 | 44 | | 2019 | 42 | 5 | 47 | | 2020 | 34 | 5 | 39 | | 2021 | 36 | 4 | 40 | | 2022 | 38 | 0 | 38 | | 2023 | 44 | 1 | 45 | | 2024 | 24 | 5 | 29 | | 2025 | 20 | 3 | 23 | | 2026 | 11 | 1 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Pulmonary Disease, Chronic Obstructive" by people in Profiles.
-
Gardner WM, Balte PP, Eckhardt CM, Morris JE, Bhatt SP, Couper DJ, Freedman ND, Jacobs DR, Kalhan R, Loehr LR, London SJ, Lutsey PL, Schwartz JE, White W, Yende S, Sanchez TR, Oelsner EC. Pipe and cigar use, lung function decline and clinical outcomes: an analysis of the NHLBI Pooled Cohorts Study. Thorax. 2026 Jun 15; 81(7):686-693.
-
Boriek AM, Gordon J, Gwon Y, Adami A, Porszasz J, Rossiter HB, Rambod M, Chandra D, Diaz AA, Kinney GL, Make BJ, McDonald MN, Regan EA, Rennard S, van Beek EJR, Casaburi R. Correlates of 5-year decline in 6-min walk distance in the COPDGene cohort. Thorax. 2026 Jun 15; 81(7):664-671.
-
Chiles JW, Rocco A, Srinivasasainagendra V, Rossiter HB, Casaburi R, Thalacker-Mercer A, Wells JM, Wan ES, Silverman EK, Cho MH, Hersh CP, Psaty BM, Gharib SA, Gao Y, O'Connor GT, Lange LA, Rich SS, Manichaikul AW, Barr RG, Ortega VE, Meyers DA, Smith AV, Tiwari HK, McDonald MN. Whole Genome Sequence Analysis of Weight Loss in 16?972 Participants With COPD Reveals Novel Risk Loci in DRAIC and RFX3. J Cachexia Sarcopenia Muscle. 2026 06; 17(3):e70293.
-
Putcha N, Bhatt SP, Bon J, Christenson SA, Han MK, Krishnan JA, Martinez FJ, Casaburi R, Crapo JD, Curtis JL, Diette GB, Dransfield MT, Eakin MN, Kalhan R, Mannino DM, Montes de Oca M, Musick H, Rowe SM, Smith BM, Salvi S, Soler X, Wedzicha JA, Wright JA, Woodruff PG, Wise RA, Chang V, Miller BE, Crim C, Drummond MB. Disease modification and progression in pre-chronic obstructive pulmonary disease: an official American Thoracic Society workshop report. Ann Am Thorac Soc. 2026 05 01; 23(5):667-688.
-
Zhang J, Moll M, Debban CL, Hobbs BD, Rijhwani H, Washko GR, Celli BR, Silverman EK, Bakke P, Oelsner EC, Barr RG, Agustà A, Faner R, Bruselle GG, Humphries SM, Lynch DA, Dupuis J, Manichaikul AW, O'Connor GT, Cho MH. Body Mass Index-related genetic factors and COPD imaging phenotypes. Ann Am Thorac Soc. 2026 05 01; 23(5):720-727.
-
Sotoudeh-Paima S, Lynch DA, Humphries SM, Samei E, Abadi E. Precise Lung Density Quantification with a Physics-based CT Harmonizer. Radiol Cardiothorac Imaging. 2026 Apr; 8(2):e250124.
-
Goel K, Ormesher R, Pratte KA, Wang Y, Nishino K, Hersh CP, Kechris K, Bowler RP, Petrache I. Vascular-related proteomic signatures in COPD with suspected pulmonary hypertension as predictors of FEV1 impairment. Respir Res. 2026 Mar 28; 27(1).
-
So K, Saferali A, Yun JH, Ryu MH, Schiavi E, Castaldi PJ, Ruvuna L, Bowler RP, Curtis JL, Hersh CP. Blood cell ratio biomarkers of systemic inflammation in chronic obstructive pulmonary disease. Respir Res. 2026 Mar 18; 27(1).
-
Rojas-Quintero J, Faner R, Chiu CY, Kue JT, Zhang Y, Sanz Rubio D, Colborg AS, Jakwerth CA, Schmidt-Weber CB, Maitland-van der Zee AH, Abdel-Aziz MI, Pilon AL, Owen CA, Plosa EJ, Kinney GL, Mc-Grath Morrow S, Gazzaneo MG, Cortes Santiago N, Lingappan K, Ledford JG, Spence J, Sucre JM, Sauler M, Wu TD, Agusti A, Wheelock A, Illi S, von Mutius E, Bowler RP, Celli B, Abman SH, Wells JM, Polverino F. Maternal smoking and CC-16: implications for lung development and COPD across the lifespan. Am J Respir Crit Care Med. 2026 03 01; 212(3):591-604.
-
Zhang C, Konigsberg IR, He Y, Zhang J, Chikowore T, Feldman WB, Hu X, Ding Y, Pasaniuc B, Chang D, Chen Q, Lasky-Su JA, Hecker J, Tobin MD, Chen J, Kalra S, Pratte KA, Im HK, Wan ES, Manichaikul A, Silverman EK, Bowler RP, Lange LA, Ortega VE, Martin AR, Cho MH, Moll MR. Multi-trait polygenic scores for COPD and COPD exacerbations implicate druggable proteins. JCI Insight. 2026 Apr 08; 11(7).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|